Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 7
2004 9
2005 2
2006 7
2007 9
2008 5
2009 8
2010 6
2011 5
2012 5
2013 8
2014 5
2015 4
2016 6
2017 7
2018 7
2019 7
2020 13
2021 6
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Results by year

Filters applied: . Clear all
Page 1
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.
Barnes NM, Ahern GP, Becamel C, Bockaert J, Camilleri M, Chaumont-Dubel S, Claeysen S, Cunningham KA, Fone KC, Gershon M, Di Giovanni G, Goodfellow NM, Halberstadt AL, Hartley RM, Hassaine G, Herrick-Davis K, Hovius R, Lacivita E, Lambe EK, Leopoldo M, Levy FO, Lummis SCR, Marin P, Maroteaux L, McCreary AC, Nelson DL, Neumaier JF, Newman-Tancredi A, Nury H, Roberts A, Roth BL, Roumier A, Sanger GJ, Teitler M, Sharp T, Villalón CM, Vogel H, Watts SW, Hoyer D. Barnes NM, et al. Among authors: villalon cm. Pharmacol Rev. 2021 Jan;73(1):310-520. doi: 10.1124/pr.118.015552. Pharmacol Rev. 2021. PMID: 33370241 Free PMC article. Review.
Gender aspects of CGRP in migraine.
Labastida-Ramírez A, Rubio-Beltrán E, Villalón CM, MaassenVanDenBrink A. Labastida-Ramírez A, et al. Among authors: villalon cm. Cephalalgia. 2019 Mar;39(3):435-444. doi: 10.1177/0333102417739584. Epub 2017 Oct 30. Cephalalgia. 2019. PMID: 29082826 Free PMC article. Review.
Wiping Out CGRP: Potential Cardiovascular Risks.
MaassenVanDenBrink A, Meijer J, Villalón CM, Ferrari MD. MaassenVanDenBrink A, et al. Among authors: villalon cm. Trends Pharmacol Sci. 2016 Sep;37(9):779-788. doi: 10.1016/j.tips.2016.06.002. Epub 2016 Jun 21. Trends Pharmacol Sci. 2016. PMID: 27338837 Review.
5-hydroxytryptamine and cardiovascular regulation.
Ramage AG, Villalón CM. Ramage AG, et al. Among authors: villalon cm. Trends Pharmacol Sci. 2008 Sep;29(9):472-81. doi: 10.1016/j.tips.2008.06.009. Trends Pharmacol Sci. 2008. PMID: 19086344 Review.
Side effects associated with current and prospective antimigraine pharmacotherapies.
González-Hernández A, Marichal-Cancino BA, MaassenVanDenBrink A, Villalón CM. González-Hernández A, et al. Among authors: villalon cm. Expert Opin Drug Metab Toxicol. 2018 Jan;14(1):25-41. doi: 10.1080/17425255.2018.1416097. Epub 2017 Dec 15. Expert Opin Drug Metab Toxicol. 2018. PMID: 29226741 Review.
CGRP inhibitors for migraine prophylaxis: a safety review.
Rivera-Mancilla E, Villalón CM, MaassenVanDenBrink A. Rivera-Mancilla E, et al. Among authors: villalon cm. Expert Opin Drug Saf. 2020 Oct;19(10):1237-1250. doi: 10.1080/14740338.2020.1811229. Epub 2020 Sep 21. Expert Opin Drug Saf. 2020. PMID: 32811190 Review.
118 results